# Ascento Cda

> Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04.

- **Business Profile:** https://optimly.ai/brand/ascento-cda
- **Dataset:** https://optimly.ai/brand/ascento-cda.json
- **Markdown:** https://optimly.ai/brand/ascento-cda/llms.txt
- **Official website:** https://ascento-cda.com
- **Slug:** ascento-cda
- **Categories:** ai-machine-learning, healthcare-it

## Overview

- **Tagline:** Transforms routine retinal OCT data into actionable Biologic Intelligence using advanced image-derived biomarkers, revealing underlying biologic disease drivers. It operates on existing OCT infrastructure without requiring new scanners or changes to clinical workflow, enabling earlier detection and precision remediation.
Source: Brand's website (https://ascento-cda.com) · 2026-10-04

- **Description:** Ascento CDA is an AI-powered platform for Biologic Intelligence that transforms routine retinal OCT data into actionable insights for earlier intervention in chronic diseases. It aims to help healthcare organizations detect biologic activity driving deterioration earlier to improve patient prioritization and provide more timely care.
Source: Brand's website (https://ascento-cda.com) · 2026-10-04

## Offerings

- **Core capabilities:**
  - The Ascento Biologic Intelligence Platform
  - IICM™ (Inflammatory
  - Immunologic & Cognitive Mapping Platform)
Source: Brand's website (https://ascento-cda.com) · 2026-10-04

- **Pricing:** Value-based healthcare model (designed for value-based care)
Source: Brand's website (https://ascento-cda.com) · 2026-10-04

## Audience

- **Target industry:** Population health organizations, healthcare providers, Accountable Care Organizations (ACOs), Payers. Focuses on clinical indications such as cognitive decline, diabetes progression, cardiovascular disease, chronic kidney disease, biologic aging, and inflammatory/immune-mediated diseases.
Source: Brand's website (https://ascento-cda.com) · 2026-10-04

Page last updated 2026-10-17.